{
  "paper_metadata": {
    "pmid": "37179432",
    "title": "MAIN TEXT",
    "extraction_summary": "Extracted BRCA2 variant information and penetrance data from a study on high-grade ovarian carcinoma."
  },
  "variants": [
    {
      "gene_symbol": "BRCA2",
      "cdna_notation": "c.4284dup",
      "protein_notation": "p.(Gln1429Serfs*9)",
      "genomic_position": null,
      "clinical_significance": "pathogenic",
      "patients": {
        "count": 1,
        "demographics": "female, age 50 at diagnosis",
        "phenotype": "high-grade ovarian carcinoma"
      },
      "penetrance_data": {
        "total_carriers_observed": 1,
        "affected_count": 1,
        "unaffected_count": null,
        "uncertain_count": null,
        "penetrance_percentage": 100.0,
        "age_dependent_penetrance": []
      },
      "individual_records": [
        {
          "individual_id": "P1",
          "age_at_evaluation": 50,
          "age_at_onset": null,
          "age_at_diagnosis": 50,
          "sex": "female",
          "affected_status": "affected",
          "phenotype_details": "high-grade ovarian carcinoma, positive family history (sister with breast cancer at age 42)",
          "evidence_sentence": "The patient reported a positive family history (sister with breast cancer at the age of 42 years) and was one of the 47 women who had undergone genetic counselling and germline testing for large BRCA1/2 rearrangements, which yielded negative results."
        }
      ],
      "functional_data": {
        "summary": "Confirmed through Sanger sequencing with an allele ratio of 80%.",
        "assays": [
          "Sanger sequencing"
        ]
      },
      "segregation_data": "Yes, segregates with disease in family.",
      "population_frequency": null,
      "evidence_level": "strong",
      "source_location": "Table 1, Row 4",
      "additional_notes": "Only BRCA2 variant confirmed at Sanger sequencing.",
      "key_quotes": [
        "Only the BRCA2 c.4284dup p. (Gln1429Serfs*9) variant was confirmed at Sanger sequencing, with an allele ratio of 80%."
      ]
    },
    {
      "gene_symbol": "BRCA2",
      "cdna_notation": "c.8940del",
      "protein_notation": "p.(Glu2981Lysfs*7)",
      "genomic_position": null,
      "clinical_significance": "likely pathogenic",
      "patients": {
        "count": 1,
        "demographics": "not specified",
        "phenotype": "not specified"
      },
      "penetrance_data": {
        "total_carriers_observed": null,
        "affected_count": null,
        "unaffected_count": null,
        "uncertain_count": null,
        "penetrance_percentage": null,
        "age_dependent_penetrance": []
      },
      "individual_records": [],
      "functional_data": {
        "summary": "Not confirmed at Sanger sequencing.",
        "assays": []
      },
      "segregation_data": null,
      "population_frequency": null,
      "evidence_level": "weak",
      "source_location": "Table 1, Row 2",
      "additional_notes": "Not confirmed at Sanger sequencing.",
      "key_quotes": [
        "The remaining four variants were not confirmed at Sanger sequencing in the tumour and were therefore considered false positive calls."
      ]
    },
    {
      "gene_symbol": "BRCA2",
      "cdna_notation": "c.3860dup",
      "protein_notation": "p.(Asn1287Lysfs*2)",
      "genomic_position": null,
      "clinical_significance": "likely pathogenic",
      "patients": {
        "count": 1,
        "demographics": "not specified",
        "phenotype": "not specified"
      },
      "penetrance_data": {
        "total_carriers_observed": null,
        "affected_count": null,
        "unaffected_count": null,
        "uncertain_count": null,
        "penetrance_percentage": null,
        "age_dependent_penetrance": []
      },
      "individual_records": [],
      "functional_data": {
        "summary": "Not confirmed at Sanger sequencing.",
        "assays": []
      },
      "segregation_data": null,
      "population_frequency": null,
      "evidence_level": "weak",
      "source_location": "Table 1, Row 3",
      "additional_notes": "Not confirmed at Sanger sequencing.",
      "key_quotes": [
        "The remaining four variants were not confirmed at Sanger sequencing in the tumour and were therefore considered false positive calls."
      ]
    },
    {
      "gene_symbol": "BRCA2",
      "cdna_notation": "c.8021dup",
      "protein_notation": "p.(Ile2675Aspfs*6)",
      "genomic_position": null,
      "clinical_significance": "likely pathogenic",
      "patients": {
        "count": 1,
        "demographics": "not specified",
        "phenotype": "not specified"
      },
      "penetrance_data": {
        "total_carriers_observed": null,
        "affected_count": null,
        "unaffected_count": null,
        "uncertain_count": null,
        "penetrance_percentage": null,
        "age_dependent_penetrance": []
      },
      "individual_records": [],
      "functional_data": {
        "summary": "Not confirmed at Sanger sequencing.",
        "assays": []
      },
      "segregation_data": null,
      "population_frequency": null,
      "evidence_level": "weak",
      "source_location": "Table 1, Row 5",
      "additional_notes": "Not confirmed at Sanger sequencing.",
      "key_quotes": [
        "The remaining four variants were not confirmed at Sanger sequencing in the tumour and were therefore considered false positive calls."
      ]
    },
    {
      "gene_symbol": "BRCA2",
      "cdna_notation": "c.1813del",
      "protein_notation": "p.(Ile605Tyrfs*9)",
      "genomic_position": null,
      "clinical_significance": "likely pathogenic",
      "patients": {
        "count": 1,
        "demographics": "not specified",
        "phenotype": "not specified"
      },
      "penetrance_data": {
        "total_carriers_observed": null,
        "affected_count": null,
        "unaffected_count": null,
        "uncertain_count": null,
        "penetrance_percentage": null,
        "age_dependent_penetrance": []
      },
      "individual_records": [],
      "functional_data": {
        "summary": "Not confirmed at Sanger sequencing.",
        "assays": []
      },
      "segregation_data": null,
      "population_frequency": null,
      "evidence_level": "weak",
      "source_location": "Table 1, Row 6",
      "additional_notes": "Not confirmed at Sanger sequencing.",
      "key_quotes": [
        "The remaining four variants were not confirmed at Sanger sequencing in the tumour and were therefore considered false positive calls."
      ]
    }
  ],
  "tables_processed": [
    {
      "table_name": "Table 1",
      "table_caption": "Patients with BRCA homopolymeric indels with allele frequency above the thresholds as compared with the control population; patients 1\u20134 were validated outliers from the study cohort, patients I and II were first identified through germline testing.",
      "variants_extracted": 6
    }
  ],
  "extraction_metadata": {
    "total_variants_found": 6,
    "extraction_confidence": "high",
    "challenges": [],
    "notes": "All relevant BRCA2 variants and penetrance data were extracted successfully."
  }
}